© 2025 MJH Life Sciences™ and Patient Care Online. All rights reserved.
AAD
Patient Care Online provides primary care physicians with essential insights from the 2025 American Academy of Dermatology (AAD) Annual Meeting. Access expert guidance, clinical updates, and actionable content on the latest advancements in dermatologic care—all tailored to enhance your practice and patient outcomes.
Your daily dose of the clinical news you may have missed.
Your daily dose of the clinical news you may have missed.
Raj Chovatiya, MD, PhD, MSCI, actually said symptoms "never" lie so, particularly in patients with skin of color, if skin signs aren't clear, ask about the patient's experience.
AAD 2025: Raj Chovatiya, MD, PhD, MSCI, well-known physician scientist, says underrepresentation in clinical trials of those with skin of color precludes an evidence-based answer.
Raj Chovatiya, MD, PhD, MSCI, discusses the complex and widely variable influences that affect the manifestations and burden of atopic dermatitis across populations.
AAD 2025: Chovatiya discusses whether melanin concentration plays a role in skin physiology and cautioned against typing with factors that are not true biologic constructs.
Your daily dose of the clinical news you may have missed.
Chovatiya, expert clinical dermatologist and researcher, points out that the term "skin of color" comprises a heterogenous set of topics, in an interview at AAD 2025.
In an interview at AAD 2025, Katrina Abuabara, MD, stressed the importance of collaboration between primary care physicians and dermatologists.
Antihistamines for itch caused by disorders like atopic dermatitis pose more problems, like sedation and fall risk, than they provide relief, according to Daniel Butler, MD.